Top

Published in:

01-12-2020 | Rheumatoid Arthritis | Review Article

Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): systematic review and meta-analysis

Authors: Zahra Bagheri-Hosseinabadi, Danyal Imani, Hassan Yousefi, Mitra Abbasifard

Published in: Clinical Rheumatology | Issue 12/2020

Abstract

Vitamin D is involved in immune system modulation as well as in calcium and bone homeostasis, hence plays a role in rheumatoid arthritis (RA) etiopathogenesis. A bulk of studies in different populations have assessed the association between the vitamin D receptor (VDR) gene polymorphisms and the risk of RA, reporting conflicting results. Therefore, we designed a meta-analysis to comprehensively evaluate the association of VDR gene polymorphisms and RA risk. All potential studies reporting the association between VDR gene polymorphisms and susceptibility to RA published till February 2020 were retrieved through systematic search of database, including Scopus and MEDLINE. Strength of pooled association was determined through calculating the pooled odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analysis was performed by stratifying the studies by population type. This meta-analysis included 23 eligible studies (21 articles) overall. We noticed that FokI SNP had a significant protective association with susceptibility to RA in the overall analysis as well as in Europeans and Asians. TaqI SNP decreased the RA risk in Africans and Arabs, but not in the overall analysis. Likewise, BsmI SNP and RA risk in the overall population analysis was not significant. Interestingly, BsmI polymorphism increased RA risk in Africans. This meta-analysis offers a significant association between VDR gene polymorphism and susceptibility to RA in both overall and ethnic-specific analysis. However, different polymorphisms acted inversely in increasing or decreasing RA risk in different populations.

McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219PubMed

Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S (2019) Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol 234(7):10018–10031PubMed

Mousavi MJ, Jamshidi A, Chopra A, Aslani S, Akhlaghi M, Mahmoudi M (2019) Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis. J Cell Physiol 234(1):335–347

Sangha O (2000) Epidemiology of rheumatic diseases. Rheumatology 39(suppl_2):3–12PubMed

Tobón GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 9(5):A288–A292PubMed

Conigliaro P, Triggianese P, de Martino E, Fonti GL, Chimenti MS, Sunzini F, Viola A, Canofari C, Perricone R (2019) Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev 18:706–713PubMed

Orozco G, Barton A (2010) Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol 6(1):61–75PubMed

Holoshitz J (2010) The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 22(3):293–298PubMedPubMedCentral

Karami J, Aslani S, Jamshidi A, Garshasbi M, Mahmoudi M (2019) Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review. Gene 702:8–16PubMed

10.

Gonzalez-Escribano M et al (1999) CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 53(3):296–300PubMed

11.

Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833PubMed

12.

Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Abou Atta I, Mevorach D, Friedman G, Ben-Yehuda A (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63(10):1227–1231PubMedPubMedCentral

13.

Razi B et al (2019) TIM family gene polymorphism and susceptibility to rheumatoid arthritis: systematic review and meta-analysis. PLoS One 14(2):e0211146PubMedPubMedCentral

14.

Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) Associations between TNFAIP3 gene polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 61(6):635–641PubMed

15.

Ebrahimiyan H, Mostafaei S, Aslani S, Jamshidi A, Mahmoudi M (2019) Studying the association between STAT4 gene polymorphism and susceptibility to rheumatoid arthritis disease: an updated meta-analysis. Iranian J Immunol 16(1):71–83

16.

Mohammadi SA et al (2018) IL27 gene single nucleotide polymorphisms confer susceptibility to rheumatoid arthritis in Iranian population. Meta Gene 18:149–152

17.

Kalueff A et al (2006) The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disord Drug Targets 5(3):363–371PubMed

18.

Adorini L (2002) Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2(7):1017–1028PubMed

19.

Ranganathan P (2009) Genetics of bone loss in rheumatoid arthritis—role of vitamin D receptor polymorphisms. Rheumatology 48(4):342–346PubMedPubMedCentral

20.

Sun J (2010) Vitamin D and mucosal immune function. Curr Opin Gastroenterol 26(6):591–595PubMedPubMedCentral

21.

Tian Y, Wang C, Ye Z, Xiao X, Kijlstra A, Yang P (2012) Effect of 1, 25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behcet's disease. Invest Ophthalmol Vis Sci 53(10):6434–6441PubMed

22.

Nagpal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26(5):662–687PubMed

23.

Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Jama 296(23):2832–2838PubMed

24.

Shoenfeld N, Amital H, Shoenfeld Y (2009) The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 5(2):99–105PubMed

25.

Uitterlinden AG et al (2004) Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J Steroid Biochem Mol Biol 89:187–193PubMed

26.

Makoui, M.H., Vitamin D receptor gene polymorphisms and the risk of the type 1 diabetes: a meta-analysis based on 40 case–control studies. Department of Immunology, School of Public Health, Tehran University of …

27.

Imani D, Razi B, Motallebnezhad M, Rezaei R (2019) Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis. BMC Neurol 19(1):339PubMedPubMedCentral

28.

Makoui MH, Imani D, Motallebnezhad M, Azimi M, Razi B (2020) Vitamin D receptor gene polymorphism and susceptibility to asthma: meta-analysis based on 17 case–control studies. Ann Allergy Asthma Immunol 124(1):57–69PubMed

29.

Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP, van Leeuwen JPTM (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338(2):143–156PubMed

30.

Sundqvist E, Bäärnhielm M, Alfredsson L, Hillert J, Olsson T, Kockum I (2010) Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet 18(12):1349–1352PubMedPubMedCentral

31.

Maalej A, Petit-Teixeira E, Michou L, Rebai A, Cornelis F, Ayadi H (2005) Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun 6(8):707–711PubMed

32.

Mosaad YM, Hammad EM, Fawzy Z, Abdal Aal IA, Youssef HM, ElSaid TO, Monir R, el-Deek BS (2014) Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis. Hum Immunol 75(5):452–461PubMed

33.

Ghelani AM, Samanta A, Jones AC, Mastana SS (2011) Association analysis of TNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheumatoid arthritis in south Asians and Caucasians of East Midlands in the United Kingdom. Rheumatol Int 31(10):1355–1361PubMed

34.

Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341PubMed

35.

Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605PubMed

36.

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMed

37.

Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMed

38.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188PubMed

39.

Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315(7109):629–634PubMedPubMedCentral

40.

Garcia-Lozano J et al (2001) Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet 28(1):89–93PubMed

41.

Lee C-K, Hong JS, Cho YS, Yoo B, Kim GS, Moon HB (2001) Lack of relationship between vitamin D receptor polymorphism. J Korean Med Sci 16:188–192PubMedPubMedCentral

42.

Goertz B, Fassbender WJ, Williams JC, Marzeion AM, Bretzel RG, Stracke H, Berliner MN (2003) Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin Exp Rheumatol 21(3):333–339PubMed

43.

Rass P, Pákozdi A, Lakatos P, Zilahi E, Sipka S, Szegedi G, Szekanecz Z (2006) Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int 26(11):964–971PubMed

44.

Hitchon CA et al (2012) Vitamin D receptor polymorphism rs2228570 (Fok1) is associated with rheumatoid arthritis in North American natives. J Rheumatol 39(9):1792–1797PubMed

45.

Hussien YM, Shehata A, Karam RA, Alzahrani SS, Magdy H, el-Shafey AM (2013) Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. Mol Biol Rep 40(5):3675–3680PubMed

46.

Karray EF, Ben Dhifallah I, Ben Abdelghani K, Ben Ghorbel I, Khanfir M, Houman H, Hamzaoui K, Zakraoui L (2012) Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet's disease in Tunisians. Joint Bone Spine 79(2):144–148PubMed

47.

Y, H., Associations of vitamin D receptor gene polymorphisms with RA in the Han population of human in China. Zhong Nan Da Xue Xue, 2013: p. 310–316

48.

Li C, W.Y., Yin H and Yin S, The association between vitamin D, vitamin D receptor polymorphism and rheumatoid arthritis. Chinese Journal of Rheumatology 2013(17): p. 164–168

49.

Shukla S et al (2014) Role of PTPN22 and VDR gene polymorphisms in susceptibility to rheumatoid arthritis: a study from Central India. Adv Genom Genet 4:79–85

50.

Tizaoui K, Kaabachi W, Ouled Salah M, Ben Amor A, Hamzaoui A, Hamzaoui K (2014) Vitamin D receptor TaqI and ApaI polymorphisms: a comparative study in patients with Behçet’s disease and rheumatoid arthritis in Tunisian population. Cell Immunol 290(1):66–71PubMed

51.

John P, Bhatti A, Ain N, Iqbal T, Sadaf T, Malik JM (2017) Case–control study of vitamin D receptor gene polymorphism in Pakistani rheumatoid arthritis patients. Rev Bras Reumatol 57(6):633–636

52.

Saad, M.N., et al., Genetic case-control study for eight polymorphisms associated with rheumatoid arthritis. PLoS One, 2015. 10(\)

53.

Di Spigna G et al (2016) Vitamin D receptor polymorphisms as tool for early screening of severe bone loss in women patients with rheumatoid arthritis. Eur Rev Med Pharmacol Sci 20(22):4664–4669PubMed

54.

Khoja SO, el-Miedany Y, Iyer AP, Bahlas SM, Balamash KS, Elshal MF (2018) Associations of vitamin D levels and vitamin D receptor genotypes with patient-reported outcome/disease activity in patients with rheumatoid arthritis. Clin Lab 64(1):51–58PubMed

55.

Mahmoud SAAH et al (2018) Vitamin D deficiency and RS731236 (taq1) vitamin D receptor gene polymorphism as possible risk factors for rheumatoid arthritis and osteoarthritis. Acta Med Austriaca 34:209

56.

Mukhtar M, Sheikh N, Suqaina SK, Batool A, Fatima N, Mehmood R, Nazir S (2019) Vitamin D receptor gene polymorphism: an important predictor of arthritis development. Biomed Res Int 2019:1–8

57.

Rodríguez-Carrio J et al (2019) Vitamin D receptor polymorphism and DHCR7 contribute to the abnormal interplay between vitamin D and lipid profile in rheumatoid arthritis. Sci Rep 9(1):1–11

58.

Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38(6):3643–3651PubMed

59.

Tizaoui K, Hamzaoui K (2015) Association between VDR polymorphisms and rheumatoid arthritis disease: systematic review and updated meta-analysis of case–control studies. Immunobiology 220(6):807–816PubMed

60.

Song G, Bae S-C, Lee Y (2016) Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis. Z Rheumatol 75(3):322–329PubMed

61.

Vinh Quốc Lương K, Nguyễn LTH (2012) The role of vitamin D in asthma. Pulm Pharmacol Ther 25(2):137–143

62.

van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, Ferreira GB, Overbergh L, Verstuyf A, Bouillon R, Roep BO, Badenhoop K, Mathieu C (2007) The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 37(2):395–405PubMed

63.

Lemos MC, Fagulha A, Coutinho E, Gomes L, Bastos M, Barros L, Carrilho F, Geraldes E, Regateiro FJ, Carvalheiro M (2008) Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum Immunol 69(2):134–138PubMed

64.

Vanessa O et al (2013) Vitamin D receptor gene expression and function in a South African population: ethnicity, vitamin D and FokI. PLoS One 8(6):e67663

Title: Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): systematic review and meta-analysis
Authors: Zahra Bagheri-Hosseinabadi
Danyal Imani
Hassan Yousefi
Mitra Abbasifard
Publication date: 01-12-2020
Publisher: Springer International Publishing
Keyword: Rheumatoid Arthritis
Published in: Clinical Rheumatology / Issue 12/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05143-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): systematic review and meta-analysis

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2020

Platelet-rich plasma for hip osteoarthritis: comparing the variables in production protocol and composition

Parotid elastography: a potential alternative to replace labial biopsy in classification of patients with primary Sjögren’s syndrome?

Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease

Can metabolic profiling provide a new description of osteoarthritis and enable a personalised medicine approach?

Disseminated anetoderma associated with antiphospholipid antibodies

Non-steroidal anti-inflammatory drugs in patients with stable ankylosing spondylitis receiving tumor necrosis factor inhibitor: continued vs withdrawn

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page